Grace Therapeutics
GRCE
15 hedge funds and large institutions have $1.53M invested in Grace Therapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
36% more funds holding
Funds holding: 11 → 15 (+4)
52% less capital invested
Capital invested by funds: $3.18M → $1.53M (-$1.64M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$24.5K |
| 2 |
Renaissance Technologies
New York
|
+$12.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.51K |
| 4 |
Citigroup
New York
|
+$186 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$186 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$188K |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$78K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$40.3K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$744 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $745K | – | – | – |
|
|
IIM
2
Intact Investment Management
Montreal,
Quebec, Canada
| $485K | – | – | – |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $258K | -$40.3K | -217 | -11% |
|
|
4
Citadel Advisors
Miami,
Florida
| $20K | +$24.5K | +132 | New |
|
|
5
Renaissance Technologies
New York
| $10K | +$12.6K | +68 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $5K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $5K | +$6.51K | +35 | New |
|
|
AGM
8
Alpine Global Management
New York
| $3K | – | – | – |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
10
Fiera Capital (Canada)
Montreal,
Quebec, Canada
| $327 | -$188K | -1,009 | -32% |
|
|
11
1832 Asset Management
Toronto,
Ontario, Canada
| – | -$78K | -353 | Closed |
|
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$744 | -4 | -67% |
|
|
13
Citigroup
New York
| – | +$186 | +1 | New |
|
|
14
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$186 | +1 | New |
|
GRCE Hedge Fund Activity: Q2 2015 in Review
15 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2015, worth a combined $1.53M — down 52% from $3.18M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GRCE positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $24.5K. The largest seller was Fiera Capital (Canada), cutting an estimated $188K.
- 15 institutional investors held Grace Therapeutics (GRCE) as of Q2 2015, up from 11 in Q1 2015.
- Funds reported $1.53M of Grace Therapeutics stock for Q2 2015, down 52% quarter-over-quarter.
- 5 funds opened new Grace Therapeutics positions in Q2 2015 and 1 closed out, a net change of +4 holders.
- The largest Grace Therapeutics buyer in Q2 2015 was Citadel Advisors, an estimated $24.5K added.
- The largest Grace Therapeutics seller in Q2 2015 was Fiera Capital (Canada), an estimated $188K sold.
Based on aggregated 13F filings for Q2 2015.